Cargando…
Impact of COVID-19 in Patients With Severe Alpha-1 Antitrypsin Deficiency: The IMCA1 Study of the EARCO Clinical Research Collaboration
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SEPAR. Published by Elsevier España, S.L.U.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9272568/ https://www.ncbi.nlm.nih.gov/pubmed/35879122 http://dx.doi.org/10.1016/j.arbres.2022.07.002 |
| _version_ | 1784744893318430720 |
|---|---|
| author | Parr, David G. Chorostowska-Wynimko, Joanna Corsico, Angelo Esquinas, Cristina McElvaney, Gerard N. Sark, Annelot D. Sucena, Maria Tanash, Hanan Turner, Alice M. Miravitlles, Marc |
| author_facet | Parr, David G. Chorostowska-Wynimko, Joanna Corsico, Angelo Esquinas, Cristina McElvaney, Gerard N. Sark, Annelot D. Sucena, Maria Tanash, Hanan Turner, Alice M. Miravitlles, Marc |
| author_sort | Parr, David G. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9272568 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | SEPAR. Published by Elsevier España, S.L.U. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-92725682022-07-11 Impact of COVID-19 in Patients With Severe Alpha-1 Antitrypsin Deficiency: The IMCA1 Study of the EARCO Clinical Research Collaboration Parr, David G. Chorostowska-Wynimko, Joanna Corsico, Angelo Esquinas, Cristina McElvaney, Gerard N. Sark, Annelot D. Sucena, Maria Tanash, Hanan Turner, Alice M. Miravitlles, Marc Arch Bronconeumol Scientific Letter SEPAR. Published by Elsevier España, S.L.U. 2022-12 2022-07-11 /pmc/articles/PMC9272568/ /pubmed/35879122 http://dx.doi.org/10.1016/j.arbres.2022.07.002 Text en © 2022 SEPAR. Published by Elsevier España, S.L.U. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Scientific Letter Parr, David G. Chorostowska-Wynimko, Joanna Corsico, Angelo Esquinas, Cristina McElvaney, Gerard N. Sark, Annelot D. Sucena, Maria Tanash, Hanan Turner, Alice M. Miravitlles, Marc Impact of COVID-19 in Patients With Severe Alpha-1 Antitrypsin Deficiency: The IMCA1 Study of the EARCO Clinical Research Collaboration |
| title | Impact of COVID-19 in Patients With Severe Alpha-1 Antitrypsin Deficiency: The IMCA1 Study of the EARCO Clinical Research Collaboration |
| title_full | Impact of COVID-19 in Patients With Severe Alpha-1 Antitrypsin Deficiency: The IMCA1 Study of the EARCO Clinical Research Collaboration |
| title_fullStr | Impact of COVID-19 in Patients With Severe Alpha-1 Antitrypsin Deficiency: The IMCA1 Study of the EARCO Clinical Research Collaboration |
| title_full_unstemmed | Impact of COVID-19 in Patients With Severe Alpha-1 Antitrypsin Deficiency: The IMCA1 Study of the EARCO Clinical Research Collaboration |
| title_short | Impact of COVID-19 in Patients With Severe Alpha-1 Antitrypsin Deficiency: The IMCA1 Study of the EARCO Clinical Research Collaboration |
| title_sort | impact of covid-19 in patients with severe alpha-1 antitrypsin deficiency: the imca1 study of the earco clinical research collaboration |
| topic | Scientific Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9272568/ https://www.ncbi.nlm.nih.gov/pubmed/35879122 http://dx.doi.org/10.1016/j.arbres.2022.07.002 |
| work_keys_str_mv | AT parrdavidg impactofcovid19inpatientswithseverealpha1antitrypsindeficiencytheimca1studyoftheearcoclinicalresearchcollaboration AT chorostowskawynimkojoanna impactofcovid19inpatientswithseverealpha1antitrypsindeficiencytheimca1studyoftheearcoclinicalresearchcollaboration AT corsicoangelo impactofcovid19inpatientswithseverealpha1antitrypsindeficiencytheimca1studyoftheearcoclinicalresearchcollaboration AT esquinascristina impactofcovid19inpatientswithseverealpha1antitrypsindeficiencytheimca1studyoftheearcoclinicalresearchcollaboration AT mcelvaneygerardn impactofcovid19inpatientswithseverealpha1antitrypsindeficiencytheimca1studyoftheearcoclinicalresearchcollaboration AT sarkannelotd impactofcovid19inpatientswithseverealpha1antitrypsindeficiencytheimca1studyoftheearcoclinicalresearchcollaboration AT sucenamaria impactofcovid19inpatientswithseverealpha1antitrypsindeficiencytheimca1studyoftheearcoclinicalresearchcollaboration AT tanashhanan impactofcovid19inpatientswithseverealpha1antitrypsindeficiencytheimca1studyoftheearcoclinicalresearchcollaboration AT turneralicem impactofcovid19inpatientswithseverealpha1antitrypsindeficiencytheimca1studyoftheearcoclinicalresearchcollaboration AT miravitllesmarc impactofcovid19inpatientswithseverealpha1antitrypsindeficiencytheimca1studyoftheearcoclinicalresearchcollaboration |